| Literature DB >> 36119355 |
Rehema White1, Mariella Marzano2, Elena Fesenko3, Alan Inman4, Glyn Jones4, Barbara Agstner4, Rick Mumford3,4.
Abstract
Innovation in environmental fields such as plant health is complex because of unbounded challenges and lack of certainty of commercial uptake. In this paper we present a Technology Readiness Level (TRL) framework, specifically to assist with assessment of technologies to support detection of tree pests and pathogens, but also for wider potential adaptation. Biosecurity can be enhanced by improved early detection of pests and pathogens, but development and deployment of new technologies requires robust scrutiny. We critically analyse the concept, practice and applicability of TRLs. Interviews revealed scientist perspectives during the development process of five novel early plant pest and pathogen detection technologies. A retrospective, collective narrative of one technology from concept to commercial deployment was undertaken. We then developed a calculator tool for assessment of biosecurity TRLs. Our findings illustrate the iterative process of technology development, the challenges in final TRLs of acquiring funding to move from proven success to viable product, inefficiencies created through the need for multiple projects for each technology and the imperative to consider the wider socio-ecological technical landscape, including policy context. End user engagement was particularly valuable at beginning and end of the TRL scale. We conclude that the TRL framework comprises a robust approach to assess technologies in that it facilitates progress tracking, evaluation of success likelihood and identification of opportunities for investment. However, its potential will only be realised for environmental management if it is integrated into the socio-ecological technical landscape and wider discussions regarding knowledge co-production and valuing nature. Supplementary Information: The online version contains supplementary material available at 10.1007/s41348-022-00599-3.Entities:
Keywords: Biosecurity; Co-design; Innovation; Knowledge implementation; Plant health surveillance; Tree health
Year: 2022 PMID: 36119355 PMCID: PMC9468069 DOI: 10.1007/s41348-022-00599-3
Source DB: PubMed Journal: J Plant Dis Prot (2006) ISSN: 1861-3829 Impact factor: 1.847
Fig. 1TRL scale (blue-laboratory environment; purple—relevant, i.e. simulated, environment; green-real environment)
Application of the TRL concept for the development of LAMP technology
| TRL | Cluster | General description | LAMP technology example |
|---|---|---|---|
| 1 | Invention | Basic principles observed: initial translation of basic science into potential new basic principles that can be used in new technologies | Advances in understanding of basic molecular biology |
| 2 | Technology concept formulated: potential applications are identified but they are speculative with no or limited analyses to support claims of a new technology | Concept development for iso-thermal DNA amplification with discovery of novel DNA replication enzymes | |
| 3 | Concept validation | Experimental proof of concept: based on preliminary study, actual research is conducted to assess technical and market feasibility of a new technology | Development of LAMP assays and Genie |
| 4 | Technology validation in laboratory: basic technological components are integrated to assess early feasibility by testing in laboratory environment | Testing of a model LAMP assay for plant diagnostic purposes | |
| 5 | Application development & prototyping | Technology validation in relevant environment: advanced testing and refinement with the focus on specific end-user requirements | Design of LAMP-based test for detecting a specific target in a specific host/matrix |
| 6 | Demonstration & technology transfer | Demonstration in relevant environment: fine-tuning of a product / process / test and real sample testing and validation | Bringing and testing of whole diagnostic including sampling, extraction and test |
| 7 | Demonstration in real environment: a product / process / test is tested by end-users | End-users (APHA, Diagnosticians) test LAMP in the field* | |
| 8 | Operational validation | System complete and qualified: a new technology performs to end-user specification and qualified through test and demonstration | Extensive field* validation & refinement by PHSI (on site technologies) or diagnosticians (laboratory-based technologies) |
| 9 | Deployment | Actual system proven in real environment: a product / process / test is fully operational and competitive | Diagnostic hand over to PHSI for routine use with support in place, e.g. access to reagents, tech support, etc |
*Field means the actual use by end-users under normal conditions (on-site, for on-site technologies; or in diagnostic laboratory for laboratory-based technologies), i.e. a routine use
TRL calculator questions used to assess readiness in plant health research
| TRL | Answer | TRL | Answer |
|---|---|---|---|
| Technology Development | 4 | Have you undertaken an assessment to identify risks to end-users? | |
| 1 | Have the basic scientific principles, which form the foundation of a new technology, been confirmed or reported elsewhere? | 6 | Has the safety of the technology been assessed and confirmed? |
| 2 | Has your technology/concept been described in sufficient detail to define future applications? | 7 | Has your technology been shown to be safe to use in the environment? |
| 2 | Have initial performance predictions of your technology been made? | 7 | Have test partners been identified? |
| 2 | Have publications or other references that outline a new technology been evaluated? | 8 | Has an aftercare strategy (maintenance, troubleshooting guide or failure analysis document, support plan) been developed? |
| 3 | Has a prospective application been specified in sufficient detail to identify all necessary technological elements? | 9 | Have all safety documents been completed? |
| 3 | Have predicted performances of all individual technology components been confirmed by repeated, rigorous and verifiable experiments or simulations in a laboratory environment? | 9 | Have all necessary end-user documents been developed and made available? |
| 3 | Has it been shown that all technology components will work together? | Business Planning | |
| 4 | Have you described real-world deployment in detail? | 1 | Have you outlined the new capabilities which might result from your new technology? |
| 4 | Has your technology (including components) been investigated in a laboratory environment with the anticipated results? | 1 | Have you identified where the capability could be used? |
| 5 | Has a detailed process which leads from a demonstration to an application been established? | 2 | Has the potential of the concept/technology to end-user groups been illustrated? |
| 5 | Has a laboratory environment been modified to approximate a real environment (i.e. relevant environment), including the development of a testing protocol? | 2 | Has a qualitative assessment of risk to the development of your technology been carried out? |
| 5 | Have demonstrations in a relevant environment—including individual and integrated testing of all key elements—produced anticipated results? | 3 | Have you asked end-users if the technology is fit for purpose? |
| 5 | Are test results in a relevant environment consistent with technical and economic viability? | 3 | Has an assessment of market opportunities been carried out? |
| 6 | Is your technology described sufficiently to finalise a deployment strategy? | 3 | Have the preliminary costs of your technology been estimated? |
| 6 | Have all relevant test issues (including scaling up) been investigated and resolved? | 3 | Has a strategy to identify and protect intellectual property been developed? |
| 6 | Has the operational performance (e.g. sensitivity, selectivity, etc.) of your technology been fully optimised in a relevant environment? | 4 | Have the needs for international or domestic patent protection been assessed? |
| 7 | Has it been shown, through repeated, rigorous and verifiable demonstrations, that your technology can function in a real environment? | 4 | Has the performance of your technology been discussed with end-users? |
| 7 | Has your technology performance been tested under critical/extreme conditions? | 5 | Has an intellectual property protection approach been implemented? |
| 7 | Have you developed a deployment plan? | 5 | Has end-user feedback been received to establish a final specification of your technology (agreement of performance needs etc.)? |
| 8 | Has your technology received satisfactory feedback after being tested by an end-user in a real environment? | 6 | Have preliminary price estimates been prepared? |
| 8 | Have all verification, validation, and accreditation tests been completed? | 6 | Has a business case been drafted for the communication with prospective end-users? |
| 9 | Has your technology been fully described in terms of conventional use and integration into customer systems? | 7 | Have patent claims, if applicable, been drafted? |
| 9 | Has it been shown that your technology operates at levels of performance, cost, quality, reliability, etc. which have been specified in the business case? | 7 | Have you done soft market testing? |
| Technology deployment | 8 | Have final cost estimates of a new technology been made? | |
| 2 | Has a preliminary technology development plan to reach deployment been outlined? | 8 | Is an agreement with at least one paying end-user (i.e. innovator or early adopter) in place? |
| 3 | Have provisional arrangements been made for real-life testing? | 9 | Has a patent application / licence (if applicable) been submitted? |
| 3 | Have you identified any hazards associated with your technology? | 9 | Has a business case been finalised and verified? |
Fig. 2Example of TRL calculator tool questions in screenshot from generic software platform